Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 16,725
- Price
- $1.28
- Value
- $21,408
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•45 filings
GCTS
GCT Semiconductor Holding, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$58,058
1 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
7
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get GCTS insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
GCTS overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
47
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
39
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 12,971
- Price
- $0.00
- Footnotes
- 4
Each Restricted Stock Unit ("RSU") represents the right to receive one share of common stock, par value $0.0001 per share ("Common Stock") of GCT Semiconductor Holding, Inc. (the "Issuer") following vesting. The RSUs become payable in Common Stock in accordance with a deferral election made by the reporting person. The number of shares subject to and issuable under the award is determined on the last day of each calendar quarter during the period April 1, 2026 through March 31, 2027 (beginning with the quarter ending June 30, 2026) by dividing $27,500 by the fair market value per share of Common Stock, which was determined to be $2.12 on September 30, 2026, rounded down to the nearest whole share. The RSUs will vest on March 31, 2027, subject to continued service through such date. No expiration date is applicable to restricted stock units.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 3,180
- Price
- $1.28
- Value
- $4,070
Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 25,453
- Price
- $1.28
- Value
- $32,580
Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 44,067
- Price
- $1.51
- Value
- $66,541
Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 10,300
- Price
- $1.30
- Value
- $13,390
Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 8,250
- Price
- $1.26
- Value
- $10,395
Shin Hyunsoo
Director
PurchaseAlert
- Shares
- 121,000
- Price
- $1.26
- Value
- $152,460
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Nov 25, 2025 | Shin Hyunsoo Director | Purchase | 16,725 | $1.28 | $21,408 | |
| Nov 21, 2025 | Shin Hyunsoo Director | Purchase | 3,180 | $1.28 | $4,070 | |
| Nov 20, 2025 | Shin Hyunsoo Director | Purchase | 25,453 | $1.28 | $32,580 | |
| Sep 12, 2025 | Shin Hyunsoo Director | Purchase | 44,067 | $1.51 | $66,541 | |
| Sep 05, 2025 | Shin Hyunsoo Director | Purchase | 10,300 | $1.30 | $13,390 | |
| Sep 04, 2025 | Shin Hyunsoo Director | Purchase | 8,250 | $1.26 | $10,395 | |
| Aug 15, 2025 | Shin Hyunsoo Director | Purchase | 121,000 | $1.26 | $152,460 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.